Announcements Trials
Browse Landscape

Phase

Phase 3 6

Status

Completed 4Active not recruiting 2

Sponsor Class

INDUSTRY 6

Study Type

Interventional 6

Sponsor

Cancer Type

Gynecologic 2Thoracic 1Head & Neck 1Genitourinary 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 18Breast Neoplasms 13Neoplasms 8Multiple Myeloma 8Melanoma 7Parkinson Disease 4, Autosomal Dominant Lewy Body 6Hematologic Neoplasms 6Urinary Bladder Neoplasms 5Prostatic Neoplasms 5Neoplasm Metastasis 5Leukemia, Lymphocytic, Chronic, B-Cell 5Colorectal Neoplasms 5Carcinoma, Renal Cell 5Thyroid Neoplasms 4Sarcoma 4Ovarian Neoplasms 4Lung Neoplasms 4Head and Neck Neoplasms 4Adenocarcinoma 4Thyroid Cancer, Papillary 3Stomach Neoplasms 3Salivary Gland Neoplasms 3Recurrence 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Neurofibromatosis 1 3Neurofibroma, Plexiform 3Neuroendocrine Tumors 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Myeloid, Acute 3

Interventions

pembrolizumab 6Saline Solution 2Paclitaxel 2Cisplatin 2lenvatinib 1Glucose 1Gemcitabine 1Doxorubicin 1Docetaxel 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Has announcements × Parkinson Disease 4, Autosomal Dominant Lewy Body × 90 days × Clear all
NCT03765918 2026-05-12

MK-3475-689

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
714 enrolled 90 charts 1 FDA
Head & Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Head and Neck Neoplasms

NCT04003636 2026-03-24

KEYNOTE-966

Merck Sharp & Dohme LLC

Phase 3 Completed
1,069 enrolled 19 charts 1 FDA
Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Bile Duct Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT03517449 2026-03-19

MK-3475-775

Eisai Inc.

Phase 3 Completed
827 enrolled 34 charts 1 FDA
Gynecologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Endometrial Neoplasms

NCT02504372 2026-03-17

PEARLS

Merck Sharp & Dohme LLC

Phase 3 Completed
1,177 enrolled 21 charts 1 FDA
Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

NCT03142334 2026-03-10

KEYNOTE-564

Merck Sharp & Dohme LLC

Phase 3 Completed
994 enrolled 10 charts 1 FDA
Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Renal Cell

NCT05116189 2026-03-09

KEYNOTE-B96

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
643 enrolled 17 charts 1 FDA
Gynecologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡